Cancer-related fatigue. ACT telehealth vs. enhanced TAU. N=44. Wright, A. A., Poort, H., Tavormina, A., Schmiege, S. J., Matulonis, U. A., Campos, S. M., ... & Arch, J. J. (2023). Pilot randomized trial of an acceptance-based telehealth intervention for women with ovarian cancer and PARP inhibitor-r
Overview
This pilot randomized trial compares an acceptance-based telehealth intervention to enhanced treatment as usual for women with ovarian cancer experiencing PARP inhibitor-related fatigue. The study includes a sample of 44 participants and was published in Gynecologic Oncology. It focuses on the clinical application of Acceptance and Commitment Therapy (ACT) via telehealth for this specific patient population.
- ID
9c1765e8b8014605- Source org
- ACBS
- Author
- Alexi A. Wright (Dana-Farber Cancer Institute), Hanneke Poort (Dana-Farber Cancer Institute), Anna Tavormina (Dana-Farber Cancer Institute), Sarah J. Schmiege (Colorado School of Public Health), Ursula A. Matulonis (Harvard University), Susana M. Campos (Harvard University), Joyce F. Liu (Harvard University), Elizabeth Slivjak (University of Colorado Boulder), Anna L Gilmour (University of Colorado Boulder), Julia M. Salinger (University of Colorado Boulder), Ashley Haggerty (University of Pennsylvania Health System), Joanna J. Arch (University of Colorado Cancer Center)
- Published
- 2023-09-13
- OA status
- green
- DOI
- 10.1016/j.ygyno.2023.08.020
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- 11
Tags
Verification
- identityok via crossref · score 0.95 · checked_at unknown
- legitimacykeep via unknown · score 1 · checked_at unknown
- linkok via http-check · 2026-07-21T15:41:41.820142+00:00
Cite this entry
BibTeX
@article{allodium:9c1765e8b8014605,
title = {Cancer-related fatigue. ACT telehealth vs. enhanced TAU. N=44. Wright, A. A., Poort, H., Tavormina, A., Schmiege, S. J., Matulonis, U. A., Campos, S. M., ... \& Arch, J. J. (2023). Pilot randomized trial of an acceptance-based telehealth intervention for women with ovarian cancer and PARP inhibitor-r},
author = {Alexi A. Wright and Hanneke Poort and Anna Tavormina and Sarah J. Schmiege and Ursula A. Matulonis and Susana M. Campos and Joyce F. Liu and Elizabeth Slivjak and Anna L Gilmour and Julia M. Salinger and Ashley Haggerty and Joanna J. Arch},
year = {2023},
journal = {ACBS},
doi = {10.1016/j.ygyno.2023.08.020},
url = {https://doi.org/10.1016/j.ygyno.2023.08.020}
}RIS
TY - JOUR TI - Cancer-related fatigue. ACT telehealth vs. enhanced TAU. N=44. Wright, A. A., Poort, H., Tavormina, A., Schmiege, S. J., Matulonis, U. A., Campos, S. M., ... & Arch, J. J. (2023). Pilot randomized trial of an acceptance-based telehealth intervention for women with ovarian cancer and PARP inhibitor-r AU - Wright, Alexi A. AU - Poort, Hanneke AU - Tavormina, Anna AU - Schmiege, Sarah J. AU - Matulonis, Ursula A. AU - Campos, Susana M. AU - Liu, Joyce F. AU - Slivjak, Elizabeth AU - Gilmour, Anna L AU - Salinger, Julia M. AU - Haggerty, Ashley AU - Arch, Joanna J. PY - 2023 PB - ACBS DO - 10.1016/j.ygyno.2023.08.020 UR - https://doi.org/10.1016/j.ygyno.2023.08.020 ER -
APA
Wright, A. A., Poort, H., Tavormina, A., Schmiege, S. J., Matulonis, U. A., Campos, S. M., Liu, J. F., Slivjak, E., Gilmour, A. L., Salinger, J. M., Haggerty, A., & Arch, J. J. (2023). Cancer-related fatigue. ACT telehealth vs. enhanced TAU. N=44. Wright, A. A., Poort, H., Tavormina, A., Schmiege, S. J., Matulonis, U. A., Campos, S. M., ... & Arch, J. J. (2023). Pilot randomized trial of an acceptance-based telehealth intervention for women with ovarian cancer and PARP inhibitor-r. ACBS. https://doi.org/10.1016/j.ygyno.2023.08.020
Related entries
- Randomized clinical trial of an Acceptance and Commitment Therapy telehealth intervention (‘REVITALIZE’) to reduce fatigue interference in women with advanced ovarian cancer on PARP inhibitors: study protocol
- Acceptance and commitment therapy for fatigue interference in advanced gastrointestinal cancer and caregiver burden: protocol of a pilot randomized controlled trial
- Cancer, Quality of Life, fatigue interference. Telephone-delivered ACT vs. telephone-delivered education/support. N=236. Mosher, C. E., Lee, S., Addington, E. L., et al. (2025). Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic B
- Patient fatigue interference and caregiver burden in advanced gastrointestinal cancer. ACT vs. education and support. N=30 dyads. Mosher, C. E., Secinti, E., Wu, W., Kashy, D. A., Kroenke, K., Bricker, J. B., Helft, P. R., Turk, A. A., Loehrer, P. J., Sehdev, A., Al-Hader, A. A., Champion, V. L., &
- Fatigue interference and health-related quality of life in lung cancer patients. ACT vs TAU. N=40. Li, H., Jin, X., Ng, M. S. N., Mann, K. F., Wang, N., & Wong, C. L. (2022). Effects of Acceptance and Commitment Therapy on fatigue interference and health-related quality of life amongst patients with
- Protocol of a randomized trial of acceptance and commitment therapy for fatigue interference in metastatic breast cancer
- Cancer, fatigue interference, and health-related quality of life. ACT vs. TAU. N=160. Li, H., Wong, C.L., Jin, X., Chong, Y.Y., & Ng, M.S.N. (2024). Effects of acceptance and commitment therapy-based intervention on fatigue interference and health-related quality of life in patients with advanced lu
- Study design and protocol for tailored Acceptance and Commitment Therapy (ACT) to optimize quality of life in women living with metastatic breast cancer
- Effectiveness of acceptance and commitment therapy on psychological flexibility, fatigue, sleep disturbance, and quality of life of patients with cancer: A meta‐analysis of randomized controlled trials
- The use of mHealth technologies to support acceptance and commitment therapy in cancer patients: Preliminary results from a randomized controlled trial.